Altre lingue Devonian Health Group Inc.

Azioni

GSD

CA2518341078

Mercato chiuso - Toronto S.E. Altri mercati azionari 15:30:00 20/06/2024			Variaz. 5gg	Var. 1 gen.
0,145 ^CAD	+3,57%		+3,57%	0,00%

25/06	Devonian Health Group Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 aprile 2024	CI
03/06	Devonian Health Group Inc. nomina André P. Boulet a Presidente del Consiglio di Amministrazione e Direttore Operativo	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

GROUPE SANTÉ DEVONIAN PARTICIPERA À LA SÉRIE DE ROADSHOWS VIRTUELS NON-BRIDGE DE RENMARK À BOSTON LE MERCREDI 26 JUIN 2024	25/06
DEVONIAN HEALTH : TO PARTICIPATE IN RENMARK’S BOSTON VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JUNE 26, 2024	25/06
Groupe Santé Devonian publie ses états financiers pour son troisième trimestre de 2024, une mise à jour de ses activités et l’engagement d’une firme de relation aux investisseurs	25/06
Devonian Health Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	25/06
Devonian Health : Reports Third Quarter 2024 Financial Results and Business Update and Announces Engagement of Investor relations Firm	25/06
Devonian Health Group Founder Assumes Chair, COO Roles	03/06
Devonian nomme André P. Boulet Président du Conseil d’Administration et Chef des Opérations	03/06
Devonian Health Group Inc. Appoints André P. Boulet to Chairman of the Board and Chief Operating Officer	03/06
Devonian Health Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	28/03
Devonian Announces Closing of a Private Placement of Units	15/03
Devonian Health Group Closes Non-Brokered Private Placement; Down Nearly 7%	14/03
Devonian annonce la clôture d’un placement privé d’unités	14/03
Devonian Health Group Inc. announced that it has received CAD 0.2238 million in funding	13/03
DEVONIAN HEALTH NAMES KATHRYN J. GREGORY TO THE BOARD OF DIRECTORS AND GRANTS STOCK OPTIONS	01/03
Devonian Health Group Inc. Appoints Kathryn J. Gregory to the Board	29/02
Devonian Announces that its Subsidiary, Altius, Launches Authorized Generic of Dexlansoprazole in Canada	28/02
Devonian annonce que sa filiale, Altius, lance un générique autorisé du dexlansoprazole (Dexilant®) au Canada	27/02
Devonian annonce un prêt à terme garantie de 2,16 million $ suivant le remboursement d’un prêt à long terme de 3,5 million $	26/02
Devonian Announces $2.16 Million Secured Term Loan Following Repayment of $3.5 Million Long Term Loan	26/02
Devonian annonce les résultats de son assemblée générale annuelle et extraordinaire des actionnaires, l’approbation de modifications à son régime d’options d’achat d’actions et l’octroi d’option d’achat d’actions	21/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Devonian Health Group Inc.

Azioni

GSD

CA2518341078

Altre lingue

Filtri